Anemia in renal insufficiency

Reviews in Clinical and Experimental Hematology

Volumn 6, Issue SUPPL. 1, 2002, Pages 12-20

  Santoro, Antonio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GLYCOPROTEIN; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; IRON;

ANEMIA; ARTICLE; COGNITIVE DEFECT; DIALYSIS; DISEASE ASSOCIATION; FATIGUE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY; KIDNEY FAILURE; QUALITY OF LIFE; SEXUAL DYSFUNCTION; ANIMAL; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; DOG; DRUG RESISTANCE; HEMODYNAMICS; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; RAT; RENAL REPLACEMENT THERAPY; REVIEW; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANEMIA; ANIMALS; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; DOGS; DRUG RESISTANCE; ERYTHROPOIETIN, RECOMBINANT; HEMODYNAMIC PROCESSES; HEMOGLOBINS; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; QUALITY OF LIFE; RATS; RATS, SPRAGUE-DAWLEY; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 0036049638     PISSN: 11270020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Cases and observations, illustrative of renal disease accompanied with the secretion of albuminous urine
2. Left ventricular mean index increase in early renal disease: Impact of decline in hemoglobin
3. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: Results from the Third National Health and Nutrition Examination Survey
4. Erythropoietin and the control of red cell production
5. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor
6. Serum erythropoietin concentration in chronic renal failure relationship to degree of anemia and excretory renal function
7. Anemia lessens and its prevention with recombinant Erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass
8. Prevention of accelerated progression of renal failure induced recombinant human erythropoietin in the rat remnant kidney
9. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients
10. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in non diabetic patients
11. Renal function in predialysis children with chronic renal failure treated with EPO
12. Beneficial influence of recombinant human erythropoieyin therapy on the rate of progression of chronic renal failure in predialysis patients
13. Contribution of anemia to progression of renal disease: A debate
14. Health-related quality of life associated with recombinant human erythropoietin therapy for pre-dialysis chronic renal disease patients
15. The US Recombinant Human Erythropoietin Predialysis Study: Double-blind, placebo controlled study of the therapeutic use of recombinant erythropoietin for anemia associated with chronic renal failure in predialysis patients
16. Recombinant human erythropoietin treatment in predialysis patients. A double-blind placebo-controlled trial
17. Effects of hemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure
18. The USRDS dialysis morbidity and mortality study: Wave 2 US renal data system
19. Uremic cardiomyopathy: An inadequate left ventricular hypertrophy
20. The cardiomyopathy of overload: An unnatural growth response in hypertrophied heart
21. Eytropoietin therapy and the cardiovascular system
22. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
23. Acute and chronic cardiovascular adjustments to induce anemia in dogs
24. Hemodynamic effects of chronic severe anemia
25. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
26. Anemia in hemodialysis patients: Variable affecting this outcome predictor
27. Determinant of left ventricular hypertrophy and systolic dysfunction in chronic renal failure
28. Working capacity is increased following recombinant human erythropoietin treatment
29. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoietin
30. Changes in left ventricular size, wall thickness and function in anemic patients treated with recombinant human erythropoietin
31. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis a prospective study
32. Vascular changes in hemodialysis patients in response to recombinant human erythropoietin
33. Recombinant human erythropoietin 10 years of clinic experience
34. The inflammatory response and epoietin sensitivity
35. The anemia of chronic disorders: Studies of marrow regulation and iron metabolism
36. NKF-K-DOQI clinical practice guidelines for anemia of chronic disease: Update 2000
37. European best practice guidelines for the management of anemia in patients with chronic renal failure
38. Higher target hemoglobin level and early anemia treatment: Different or complementary concepts?
39. Erythropoietin mimetic peptides and the future
40. An erytrhopoietin fusion protein comprised of identical repeating domains exhibits enhanced biological properties
41. Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human eruthropoietin gene
42. Development and characterization of novel erythropoiesis stimulating protein (NESP)
43. Physical performance and associated electrolyte changes after haemoglobin normalization: A comparative study in haemodialysis patients